306 related articles for article (PubMed ID: 31741284)
1. Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.
Shouse G; Nikolaenko L
Curr Hematol Malig Rep; 2019 Dec; 14(6):570-576. PubMed ID: 31741284
[TBL] [Abstract][Full Text] [Related]
2. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
[TBL] [Abstract][Full Text] [Related]
3. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
[TBL] [Abstract][Full Text] [Related]
4. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
Durham GA; Williams JJL; Nasim MT; Palmer TM
Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
[TBL] [Abstract][Full Text] [Related]
5. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.
Seif F; Khoshmirsafa M; Aazami H; Mohsenzadegan M; Sedighi G; Bahar M
Cell Commun Signal; 2017 Jun; 15(1):23. PubMed ID: 28637459
[TBL] [Abstract][Full Text] [Related]
6. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
Waldmann TA; Chen J
Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
[TBL] [Abstract][Full Text] [Related]
7. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
8. The JAK/STAT signaling cascade in gastric carcinoma (Review).
Khanna P; Chua PJ; Bay BH; Baeg GH
Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases.
Gao Q; Liang X; Shaikh AS; Zang J; Xu W; Zhang Y
Curr Drug Targets; 2018; 19(5):487-500. PubMed ID: 27928945
[TBL] [Abstract][Full Text] [Related]
10. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
Yang X; Tang Z; Zhang P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
[TBL] [Abstract][Full Text] [Related]
11. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
Pérez C; González-Rincón J; Onaindia A; Almaráz C; García-Díaz N; Pisonero H; Curiel-Olmo S; Gómez S; Cereceda L; Madureira R; Hospital M; Suárez-Massa D; Rodriguez-Peralto JL; Postigo C; Leon-Castillo A; González-Vela C; Martinez N; Ortiz-Romero P; Sánchez-Beato M; Piris MÁ; Vaqué JP
Haematologica; 2015 Nov; 100(11):e450-3. PubMed ID: 26294736
[No Abstract] [Full Text] [Related]
12. SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.
Lahera A; López-Nieva P; Alarcón H; Marín-Rubio JL; Cobos-Fernández MÁ; Fernández-Navarro P; Fernández AF; Vela-Martín L; Sastre I; Ruiz-García S; Llamas P; López-Lorenzo JL; Cornago J; Santos J; Fernández-Piqueras J; Villa-Morales M
Br J Haematol; 2023 May; 201(4):718-724. PubMed ID: 36786170
[TBL] [Abstract][Full Text] [Related]
13. The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.
Roger I; Milara J; Montero P; Cortijo J
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067108
[TBL] [Abstract][Full Text] [Related]
14. Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications.
Park H; Lee S; Lee J; Moon H; Ro SW
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762066
[TBL] [Abstract][Full Text] [Related]
15. Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer.
Yunianto I; Currie M; Chitcholtan K; Sykes P
J Obstet Gynaecol Res; 2023 Nov; 49(11):2563-2574. PubMed ID: 37565583
[TBL] [Abstract][Full Text] [Related]
16. Jak/Stat pathway in Waldenström's macroglobulinemia.
Hodge LS; Ansell SM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):112-4. PubMed ID: 21454207
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of JAK/STAT pathway modulation in mood disorders.
Shariq AS; Brietzke E; Rosenblat JD; Pan Z; Rong C; Ragguett RM; Park C; McIntyre RS
Rev Neurosci; 2018 Dec; 30(1):1-7. PubMed ID: 29902157
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review.
Ashrafizadeh M; Rafiei H; Mohammadinejad R; Afshar EG; Farkhondeh T; Samarghandian S
Phytother Res; 2020 Aug; 34(8):1745-1760. PubMed ID: 32157749
[TBL] [Abstract][Full Text] [Related]
19. Targeting the JAK/STAT Signaling Pathway for Breast Cancer.
Shao F; Pang X; Baeg GH
Curr Med Chem; 2021; 28(25):5137-5151. PubMed ID: 33290193
[TBL] [Abstract][Full Text] [Related]
20. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
